Cadrenal Therapeutics (CVKD) News Today → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free CVKD Stock Alerts $0.49 +0.01 (+2.08%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFavourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stockfinance.yahoo.com - April 20 at 1:08 PMCadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024finance.yahoo.com - April 11 at 5:11 PMCadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024prnewswire.com - April 11 at 4:30 PMCadrenal Therapeutics Gets FDA Orphan Drug Designation for Tecarfarinmarketwatch.com - April 11 at 7:09 AMCadrenal Therapeutics: FDA Grants Orphan Drug Designation For Tecarfarin; Stock Jumpsmarkets.businessinsider.com - April 9 at 11:01 AMPonte Vedra-based Cadrenal Therapeutics receives second FDA orphan drug designationbizjournals.com - April 9 at 11:01 AMCadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Heartsprnewswire.com - April 9 at 9:00 AMAnalysts Conflicted on These Healthcare Names: Cadrenal Therapeutics, Inc. (CVKD), Protara Therapeutics (TARA) and Spruce Biosciences (SPRB)markets.businessinsider.com - March 14 at 8:55 PMCadrenal Therapeutics, Inc.: Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Updatefinanznachrichten.de - March 11 at 1:55 PMCadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Updatefinance.yahoo.com - March 11 at 1:55 PMCadrenal Therapeutics to Participate at Technology and Heart Failure Therapeutics (THT) Conferenceprnewswire.com - February 26 at 9:00 AMCadrenal Therapeutics Inc CVKDmorningstar.com - February 14 at 9:00 PMCadrenal Therapeutics, Inc.: Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trialfinanznachrichten.de - February 8 at 4:01 PMCadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trialfinance.yahoo.com - February 8 at 11:00 AMCadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditionsfinance.yahoo.com - January 31 at 10:37 AMHere's Why We're Not Too Worried About Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situationfinance.yahoo.com - January 30 at 9:29 AMCadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024finance.yahoo.com - January 24 at 10:48 AMCadrenal Therapeutics to Present at the Biotech Showcase on January 8, 2024 Alongside the J.P. Morgan Annual Healthcare Conferencefinance.yahoo.com - January 4 at 10:17 AMCadrenal Therapeutics Stock (NASDAQ:CVKD), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 19 at 8:29 AMCadrenal Therapeutics, Inc. (CVKD)uk.finance.yahoo.com - December 11 at 1:57 PMCadrenal Therapeutics to Present at the NobleCon 19 Conference on December 4, 2023finance.yahoo.com - November 30 at 5:43 PMHC Wainwright & Co. Initiates Coverage of Cadrenal Therapeutics (CVKD) with Buy Recommendationmsn.com - November 21 at 10:23 AMCadrenal Therapeutics reports Q3 resultsmsn.com - November 9 at 1:17 PMCadrenal Therapeutics Provides Third Quarter 2023 Corporate Updatefinance.yahoo.com - November 9 at 1:17 PMCadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conferencefinance.yahoo.com - October 9 at 7:25 PMCadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congressfinance.yahoo.com - September 5 at 12:46 PMCadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)finance.yahoo.com - August 30 at 6:47 PMCadrenal Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - August 28 at 6:29 PMCVKD Cadrenal Therapeutics, Inc.seekingalpha.com - August 18 at 10:09 AMCadrenal Therapeutics Provides Second Quarter 2023 Corporate Updatefinance.yahoo.com - August 10 at 9:57 AMCadrenal Therapeutics Expands Focus for Tecarfarin to Patients with Implanted Medical Devices for Heart Diseasesfinance.yahoo.com - August 1 at 6:24 PMCadrenal Therapeutics Announces Appointment of Robert Lisicki to Board of Directorsfinance.yahoo.com - July 24 at 1:11 PMPonte Vedra-based Cadrenal Therapeutics set to raise $7.5Mbizjournals.com - July 14 at 8:47 AMCadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rulesfinance.yahoo.com - July 12 at 3:52 PMThe 3 Hottest IPOs to Buy Before They Soarfinance.yahoo.com - July 6 at 1:25 AMBest and worst performing healthcare IPOs of 2023, so farmsn.com - July 4 at 12:29 PMCadrenal Therapeutics to Participate in the 2023 BIO International Convention in Bostonfinance.yahoo.com - June 1 at 9:45 AMCadrenal Therapeutics Provides First Quarter 2023 Corporate Updatefinance.yahoo.com - May 10 at 12:04 PMCadrenal Therapeutics to Participate in the Lytham Partners Spring 2023 Investor Conferencefinance.yahoo.com - May 9 at 8:55 PMCadrenal Therapeutics Provides Fiscal Year 2022 Corporate Updatefinance.yahoo.com - March 30 at 12:23 PMCadrenal Therapeutics Recognizes National Kidney Month with Goal to Advance Tecarfarin for Severely Underserved Patient Populationfinance.yahoo.com - March 9 at 6:14 PMCadrenal celebrates IPO with bell ringing at Nasdaqbizjournals.com - February 9 at 8:36 AMCadrenal Therapeutics to Ring the NASDAQ Stock Market Closing Bell on February 8, 2023finance.yahoo.com - February 8 at 6:04 PMCadrenal Therapeutics to Participate in the 2023 BIO CEO & Investor Conferencefinance.yahoo.com - February 6 at 2:54 PMCadrenal Therapeutics Announces Formation of Scientific Advisory Boardfinance.yahoo.com - February 1 at 1:40 PMCadrenal Therapeutics Inc (CVKD)investing.com - January 28 at 6:42 PMCadrenal Therapeutics (Nasdaq: CVKD) Announces Closing of Initial Public Offeringfinance.yahoo.com - January 24 at 4:43 PMCadrenal Shares Rise 7% After Tecarfarin's FDA Fast-Track Designationmarketwatch.com - January 24 at 11:42 AMWhat's Going On With Cadrenal Therapeutics Stock Todaynews.yahoo.com - January 24 at 11:42 AMmarketbeat.com - January 23 at 9:40 AM Get Cadrenal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CVKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… CVKD Media Mentions By Week CVKD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVKD News Sentiment▼0.000.36▲Average Medical News Sentiment CVKD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVKD Articles This Week▼00▲CVKD Articles Average Week Get Cadrenal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CVKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADXS News Today PULM News Today KTTA News Today ADIL News Today TFFP News Today ENVB News Today SHPH News Today VCNX News Today CANF News Today TRVN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVKD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
